Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06996834 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

StatusRecruiting
PhaseNot applicable
Started2025-07-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jul 1, 2026 → Nov 1, 2026
See other at-risk trials from Assiut University

Amendment history

2026-09-23
Primary completion pushed: 2026-07-01 → 2026-11-01
Completion pushed: 2026-11-01 → 2027-02-01
2026-04-26
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
2025-05-21
Original filing
Assiut University
1,604 trials monitored
See 18 trials at risk
This randomized controlled trial aims to compare the efficacy and safety of high-velocity nasal insufflation (HVNI) versus standard noninvasive ventilation (NIV) in adult patients experiencing acute exacerbations of community-acquired pneumonia (CAP) accompanied by hypoxemic respiratory failure. The primary focus is on assessing treatment failure within 48 hours, defined as the need for intubation or death. Secondary outcomes include evaluations of gas exchange parameters, patient comfort levels, duration of ICU stay, and 28-day mortality rates.
Trial Details
NCT Number NCT06996834
Lead Sponsor Assiut University
Conditions Community-acquired Pneumonia, Community-Acquired Infections
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-22